Patient-specific comorbidities as prognostic variables for survival in myelofibrosis.
Sochacki AL, Bejan CA, Zhao S, Patel A, Kishtagari A, Spaulding TP, Silver AJ, Stockton SS, Pugh K, Dorand RD, Bhatta M, Strayer N, Zhang S, Snider CA, Stricker T, Nazha A, Bick AG, Xu Y, Savona MR.
Sochacki AL, et al. Among authors: pugh k.
Blood Adv. 2023 Mar 14;7(5):756-767. doi: 10.1182/bloodadvances.2021006318.
Blood Adv. 2023.
PMID: 35420683
Free PMC article.